CLBT — Cellebrite DI Balance Sheet

0.000.00%

Last trade - 00:00

TechnologyBalancedLarge CapHigh Flyer

Annual balance sheet for Cellebrite DI, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	20-F	20-F	20-F
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	238	182	184	303	447
Net Total Accounts Receivable
Net Total Receivables	69.5	73.1	85.8	83.4	89.6
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	324	273	296	422	568
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	16.1	16.8	32.9	30.2	27.6
Net Goodwill
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	364	340	403	533	691
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	159	187	208	254	296
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	199	413	329	499	355
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	165	-73.3	73.9	34.2	336
Total Liabilities & Shareholders' Equity	364	340	403	533	691
Total Common Shares Outstanding